(R)-4-Isopropyl-2-(4-methoxy-6-methylpyridin-2-yl)-4,5-dihydrooxazole, 98%, 1g

(Z)-2-((Furan-2-ylmethyl)sulfinyl)-N-(4-((3-(piperidin-1-ylmethyl)pyridin-2-yl)oxy)but-2-en-1-yl)acetamide, 95.0%, 250mg

Methyl 3-chloro-4-hydroxybenzoate, 98.0%, 1g

EUPATILIN, 95.0%, 10mg

tert-butyl (8-anti)-3-azabicyclo[3.2.1]oct-8-ylcarbamate, 95.0%, 1g

tert-butyl methyl ether, min. 99.5%, for synthesis, 2.5 l, glass packaging

(5-Bromo-2-ethoxypyridin-3-yl)methanol, 97%, 500mg

5-Bromo-2,3-dimethylpyrazine, 95.0%, 100mg

5-(tert-Butyloxycarbonyamino)methyl-3-phenyl-[1,2,4]oxadiazole, 95.0%, 1g

Benzenemethanol, 3-bromo-4-(trifluoromethyl), 95.0%, 100mg

N-[[(2S)-1-[[5-(4-Fluorophenyl)-2-methyl-4-thiazolyl]carbonyl]-2-piperidinyl]methyl]-4-benzofurancarboxamide, 99%, 250mg

2-Chloro-9-isopropyl-N-(4-methoxybenzyl)-9H-purin-6-amine, 95.0%, 100mg

4-Methyl-3-(trifluoromethyl)benzoic acid, 98.0%, 1g